Proceedings of the 2019 Viral Clearance Symposium, Session 3: Continuous Processing

References

1. 1.↵
   1. Angelo J.,
   2. Chollangi S.,
   3. Müller‐Späth T.,
   4. Jusyte S.,
   5. Xu X.,
   6. Ghose S.,
   7. Li Z.

   Virus Clearance Validation across Continuous Capture Chromatography. Biotechnol. Bioeng. 2019, 116 (9), 2275–2284.

   OpenUrl
2. 2.↵
   1. Chiang M.‐J.,
   2. Pagkaliwangan M.,
   3. Lute S.,
   4. Bolton G.,
   5. Brorson K.,
   6. Schofield M.

   Validation and Optimization of Viral Clearance in a Downstream Continuous Chromatography Setting. Biotechnol. Bioeng. 2019, 116 (9), 2292–2302.

   OpenUrl
3. 3.↵
   1. Lute S.,
   2. Kozaili J.,
   3. Johnson S.,
   4. Kobayashi K.,
   5. Strauss D.

   Development of Small-Scale Models to Understand the Impact of Continuous Downstream Bioprocessing on Integrated Virus Filtration. Biotechnol. Prog. 2020, 36 (3), e2962.

   OpenUrl
4. 4.↵
   1. Brown M. R.,
   2. Orozco R.,
   3. Coffman J.

   Leveraging Flow Mechanics to Determine Critical Process and Scaling Parameters in a Continuous Viral Inactivation Reactor. Biotechnol. Bioeng. 2020, 117 (3), 637–645.

   OpenUrl
5. 5.↵
   1. Martins D. L.,
   2. Sencar J.,
   3. Hammerschmidt N.,
   4. Tille B.,
   5. Kinderman J.,
   6. Kreil T. R.,
   7. Jungbauer A.

   Continuous Solvent/Detergent Virus Inactivation Using a Packed-Bed Reactor. Biotechnol. J. 2019, 14 (8), e1800646.

   OpenUrl
6. 6.↵
   1. Schofield M.,
   2. Jones K.

   Assessing Viral Inactivation for Continuous Processing, BioPharm International Web site. https://www.biopharminternational.com/view/assessing-viral-inactivation-continuous-processing (accessed September 16, 2021).
7. 7.↵
   1. Johnson S. A.,
   2. Roush D.

   Proceedings of the 2017 Viral Clearance Symposium, Session 6: Ensuring Viral Safety in Continuous Processing. PDA J. Pharm. Sci. Technol. 2018, 72 (5), 516–524.

   OpenUrlAbstract/FREE Full Text